Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Alexandros Stefanidis,
Discover the details of the session
This interesting session provided useful and updated information in terms of vascular pathology from the thoracic aorta level to microvascular physiology and function. The speakers reminded the audience of well known pathophysiological principles of cardiovascular disease, while stressing in detail the interrelation of heart function and peripheral vessels.Prof. Alan Gordon Fraser (Cardiff, UK) gave a talk regarding aortic stiffness and its additive risk in patients at cardiovascular risk. Increased aortic stiffness, as reflected by an increased pulse wave velocity or more specifically diagnosed by using magnetic resonance imaging (MRI) technology, is significantly and independently associated with higher risk of cardiovascular morbidity and mortality. Important information coming from basic research, (which, however, has to be thoroughly investigated before its wider clinical application), concerns the more beneficial contribution of atenonol to aortic stiffness in patients with Marfan syndrome as compared to renin angiotensin axis pharmacological agents.Dr Javier Bermejo (Madrid, Spain), presented updated data regarding the important role of valvuloarterial impedance (Zva) in patients with aortic valve stenosis (AS). During his speech, he elucidated the contribution of valvuloarterial impedance as a measure of global afterload in AS, which takes systemic arterial compliance into account in addition to the severity of AS. The audience also had the opportunity to be informed about innovative haemodynamic data coming from pre- and post-transcatheter aortic valve interventions. A crucial moment of Dr Bermejo’s lecture was the reminder that each echocardiographic study, especially in AS cases, should provide information regarding the blood pressure of the patient during the index study, since this parameter affects the final assessment of the effective aortic orifice.Dr Serge Kownator (Thionville, France) comprehensively developed on the microvascular contribution to the apprehension of circulatory physiology. The speaker recalled well known (flow-mediated dilation , FMD) and other, innovative methods of how to non-invasively assess the functionality of small vessels in several conditions.Dr Muriel Sprynger (Liege, Belgium) spoke about vascular calcification and proved that this pathophysiological process is a clear ageing phenomenon. After categorizing vessel calcification to 3 distinct mechanisms, she concluded that this process is frequently observed but neglected in everyday clinical practice, and suggests unequivocally increased cardiovascular morbidity and mortality, whereas there are still no therapeutic strategies against it.
Vascular imaging, physiology and outcome
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved